AstraZeneca SG signs MOU with tech partners

The partnerships aim to improve care delivery and patient outcomes.

AstraZeneca Singapore signed a memorandum of understanding (MOU) with tech partners Respiree, OncoShot, Thermaiscan, Ubie and Hewlett Packard Enterprise on 25 November. The partnerships aim to pilot data and artificial intelligence-driven projects in Singapore to drive healthcare improvement.

"AstraZeneca's A.Catalyst Network brings together partners across the public and private sectors to unlock the power of innovation and transform care delivery for improved patient experience and outcomes", said country president Vinod Narayanan. "Facilitating such partnerships will drive improvement in the healthcare ecosystem while providing patients with access to new digital healthcare solutions that can revolutionise the management of challenging diseases such as cancer, diabetes, heart failure and respiratory diseases."

The partnership was witnessed by Singapore's Ministry of Health, the Government Offices of Sweden, the Embassy of Sweden in Singapore, and Business Sweden.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The partnerships aim to improve care delivery and patient outcomes.
New data highlighted that remote patient management digital health help improve clinical outcomes.
The new point-of-care test offers an accuracy rate of up to 93%.
The 2021 healthcare budget allocation is at MYR31.9b.
The acquisition cements Doctor Anywhere's position as Asia's leader in telehealth.
This came as the life sciences company opened its new bioanalytical laboratory.
Artificial intelligence in healthcare will be the first area of focus.
The VCAT addresses the challenges of dementia screening in multi-lingual countries.
Famous fruit shake shop Fruitas has inked a deal to acquire 100% shares of Surehealth.
The minister addressed the Parliament about intensive care units and hospital capacity.
The partnership aims to accelerate precision medicine adoption in SEA.
The PHP 26m project is an EMR system on its way towards commercialisation.
The centre aims to cut gene decoding waiting time in the region to under 30 days.
Currently, the Union Budget 2021-2022 allocates 1.2% of GDP to public health.
Two companies have bid to make the hospital group private.